News | PET-MRI | May 23, 2019

French study uses MR Solutions’ cryogen-free 3T PET/MRI scanner to investigate promising improvements in imaging capabilities

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.


May 23, 2019 — Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (NPs) using multimodal positron emission tomography/magnetic resonance imaging (PET/MRI) offers promising improvements in nuclear imaging capabilities. The paper is published in the American Chemical Society journal ACS Omega.1

Using an MR Solutions cryogen-free, 3 Tesla (3T) scanner with a PET clip on the sequential images were found to be highly beneficial providing high spatial resolution, high sensitivity and high technical maturity with a low radiation dose.

Prof. Nadine Millot, principal investigator on the study commented, “The combination of simultaneous MRI/PET imaging is very attractive because it allies the high resolution of MRI with the high sensitivity of PET to obtain accurate anatomical and quantitative information at the same time.” This pioneering imaging agent highlights activity in the liver, spleen, lungs and kidneys before being gradually excreted from the body, with no cytotoxicity observed.

This is the first successful grafting of PEG and MANOTA chelator on prefunctionalized iron oxide NPs synthesized under continuous hydrothermal conditions for bimodal PET/MRI imaging and shows the potential benefits.

For more information: www.pubs.acs.org

 

Reference

1. Thomas G., Boudon J., Maurizi L., et al. Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging. ACS Omega, published online Feb. 5, 2019. https://doi.org/10.1021/acsomega.8b03283

Related Content

News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
News | Women's Health

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

Time October 05, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

Time September 20, 2021
arrow
News | Radiation Oncology

September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and ...

Time September 17, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Time September 16, 2021
arrow
Feature | PET Imaging | By Todd Sasser, Ph.D.

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to ...

Time September 14, 2021
arrow
News | PET Imaging

September 13, 2021 — Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and ...

Time September 13, 2021
arrow
Subscribe Now